D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 84 Citations 43,439 242 World Ranking 252 National Ranking 126
Medicine D-index 83 Citations 41,451 246 World Ranking 8234 National Ranking 4494

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

His primary scientific interests are in Aspergillosis, Microbiology, Mycosis, Internal medicine and Surgery. His research in Aspergillosis intersects with topics in Amphotericin B, Voriconazole, Caspofungin, Intensive care medicine and Pharmacotherapy. While the research belongs to areas of Microbiology, Thomas F. Patterson spends his time largely on the problem of Mutant, intersecting his research to questions surrounding Virulence, Gene cluster, Gliotoxin and Gene expression.

His Mycosis study is concerned with the field of Immunology as a whole. Thomas F. Patterson focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Aspergillus and, in certain cases, Systematic review, Oncology, Real-time polymerase chain reaction, Latex fixation test and Immunoassay. His research integrates issues of Gastroenterology, Amphotericin B deoxycholate and Epidemiology in his study of Surgery.

His most cited work include:

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3691 citations)
  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis (2622 citations)
  • Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America (2130 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Microbiology, Aspergillosis, Fluconazole, Immunology and Mycosis. The various areas that Thomas F. Patterson examines in his Aspergillosis study include Amphotericin B, Aspergillus fumigatus, Intensive care medicine, Internal medicine and Voriconazole. Thomas F. Patterson interconnects Cancer, Epidemiology and Disease in the investigation of issues within Intensive care medicine.

His studies in Internal medicine integrate themes in fields like Gastroenterology and Surgery. He has researched Fluconazole in several fields, including Candida auris, Cryptococcus neoformans and Candida albicans. His work carried out in the field of Mycosis brings together such families of science as Opportunistic infection, Chemotherapy and Pathology.

He most often published in these fields:

  • Microbiology (40.06%)
  • Aspergillosis (31.02%)
  • Fluconazole (29.82%)

What were the highlights of his more recent work (between 2014-2021)?

  • Microbiology (40.06%)
  • In vivo (8.73%)
  • Pharmacology (18.37%)

In recent papers he was focusing on the following fields of study:

Thomas F. Patterson mainly focuses on Microbiology, In vivo, Pharmacology, In vitro and Aspergillosis. His work on Amphotericin B as part of general Microbiology study is frequently connected to Rhizopus arrhizus var. arrhizus, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Thomas F. Patterson works mostly in the field of Pharmacology, limiting it down to topics relating to Candida albicans and, in certain cases, Organ transplantation, as a part of the same area of interest.

His Aspergillosis research integrates issues from Post-hoc analysis, Internal medicine, Voriconazole and Surgery. His studies deal with areas such as Gastroenterology and Immunology as well as Internal medicine. He has included themes like Pulmonary aspergillosis, Lung, Transplantation and Intensive care medicine in his Voriconazole study.

Between 2014 and 2021, his most popular works were:

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America (1008 citations)
  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial (395 citations)
  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Thomas F. Patterson focuses on Intensive care medicine, Voriconazole, Aspergillosis, Fluconazole and Microbiology. His Intensive care medicine research is multidisciplinary, relying on both Clinical research, Disease, Consensus criteria, Coronavirus disease 2019 and Azole resistance. His biological study spans a wide range of topics, including Pulmonary aspergillosis, Lung, Aspergillus, Severe acute respiratory syndrome coronavirus 2 and Respiratory distress.

Thomas F. Patterson interconnects Internal medicine and Surgery in the investigation of issues within Aspergillosis. His studies deal with areas such as Multiple drug resistance, Cryptococcus neoformans, Candida albicans, Pharmacology and Candida auris as well as Fluconazole. His Microbiology research integrates issues from In vitro and Chrysosporium.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)

3691 Citations

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)

3478 Citations

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht.
Clinical Infectious Diseases (2008)

3338 Citations

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

S. Ascioglu;J. H. Rex;B. de Pauw;J. E. Bennett.
Clinical Infectious Diseases (2002)

2739 Citations

Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman.
Clinical Infectious Diseases (2016)

1558 Citations

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

Dimitrios P. Kontoyiennis;Kieren A. Marr;Benjamin J. Park;Barbara D. Alexander.
Clinical Infectious Diseases (2010)

1519 Citations

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

Peter G. Pappas;Barbara D. Alexander;David R. Andes;Susan Hadley.
Clinical Infectious Diseases (2010)

1251 Citations

Practice Guidelines for Diseases Caused by Aspergillus

David A. Stevens;David A. Stevens;David A. Stevens;Virginia L. Kan;Marc A. Judson;Marc A. Judson;Vicki A. Morrison.
Clinical Infectious Diseases (2000)

1091 Citations

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes

Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz.
Medicine (2000)

979 Citations

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial

Thomas J. Walsh;Issam Raad;Thomas F. Patterson;Pranatharthi Chandrasekar.
Clinical Infectious Diseases (2007)

784 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas F. Patterson

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 251

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 245

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 222

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 187

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 173

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 166

David W. Denning

David W. Denning

University of Manchester

Publications: 156

Kieren A. Marr

Kieren A. Marr

Johns Hopkins University School of Medicine

Publications: 139

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 135

John R. Perfect

John R. Perfect

Duke University

Publications: 131

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 128

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 119

Raoul Herbrecht

Raoul Herbrecht

University of Strasbourg

Publications: 118

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 117

Andreas H. Groll

Andreas H. Groll

Boston Children's Hospital

Publications: 116

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 115

Something went wrong. Please try again later.